VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs has submitted a declaration to the stock exchanges stating that it does not qualify as a 'large corporate entity' under the SEBI framework dated November 26, 2018. Under this SEBI circular, companies with outstanding borrowings above a certain threshold are classified as large corporates and are required to raise at least 25% of their incremental borrowings through the bond market. By confirming it falls outside this category, the company signals that its borrowing levels are below the prescribed threshold. The filing was made by the Managing Director on April 3, 2025. This is a routine annual compliance submission with no new financial or strategic information disclosed.
No material impact on shareholders or stock price — this is a standard regulatory declaration confirming the company's borrowing levels are below SEBI's large corporate threshold, meaning no additional bond-market borrowing obligations apply.